Related Experiment Videos
Oxidation of brefeldin A
B Proksa1, D Uhrin, J Adamcová
1Institute of Chemistry, Slovak Academy of Sciences, Bratislava.
Die Pharmazie
|August 1, 1992
Summary
New brefeldin A derivatives were synthesized and demonstrated enhanced cytotoxic and antifungal activities. These findings suggest potential for novel therapeutic applications against leukemia and fungal infections.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Brefeldin A is a macrolide antibiotic with known biological activities.
- Exploring structural modifications of natural products can lead to compounds with improved therapeutic properties.
Purpose of the Study:
- To synthesize novel brefeldin A derivatives.
- To evaluate the cytotoxic and antifungal activities of the synthesized compounds.
Main Methods:
- Oxidation of brefeldin A using pyridinium chlorochromate adsorbed on alumina.
- Cytotoxicity testing on P388 leukemia cells.
- Antifungal activity assessment against Candida albicans.
Main Results:
- Two new compounds were synthesized: a cyclopent[f]oxacyclotridecin-1,4,13-trione derivative and 13-oxobrefeldin.
- The synthesized compounds exhibited higher cytotoxic activity against P388 leukemia cells compared to brefeldin A and its other derivatives.
- 13-Oxobrefeldin demonstrated superior antifungal activity against Candida albicans compared to brefeldin A.
Conclusions:
- The synthesized brefeldin A derivatives possess enhanced cytotoxic and antifungal properties.
- These novel compounds represent promising candidates for further development as therapeutic agents.